Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Conte

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
Clinical Pharmacokinetics|March 27, 1998
Pharmacokinetic optimisation of the treatment of cancer with high dose zidovudineR Danesi, A Falcone, P F Conte, et al.
Oncology (Williston Park, N.Y.)|March 28, 1998
Paclitaxel plus epirubicin in advanced breast cancerP F Conte, A Gennari, B Salvadori, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamideE Campora, A Vidali, S Mammoliti, et al.
Haematologica|September 5, 2001
Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell supportR Consolini, A Calleri, C Bengala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Tamoxifen rechallengeP Pronzato, A Ardizzoni, R Lionetto, et al.
Cancer Treatment Reviews|September 25, 2017
Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?F Miglietta, M V Dieci, G Griguolo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1985
Regional intra-arterial chemotherapy of metastatic liver cancerL Santi, D Civalleri, P F Conte, et al.
European Journal of Gynaecological Oncology|January 1, 1994
Therapeutic experience of the North-West Oncology Group (GONO) on ovarian carcinomaP F Conte, A Gadducci, P Fioretti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1987
4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot studyM Bruzzone, S Chiara, A Falcone, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancerP F Conte, A Alama, R Favoni, et al.
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
Clinical Pharmacokinetics|March 27, 1998
Pharmacokinetic optimisation of the treatment of cancer with high dose zidovudineR Danesi, A Falcone, P F Conte, et al.
Oncology (Williston Park, N.Y.)|March 28, 1998
Paclitaxel plus epirubicin in advanced breast cancerP F Conte, A Gennari, B Salvadori, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamideE Campora, A Vidali, S Mammoliti, et al.
Haematologica|September 5, 2001
Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell supportR Consolini, A Calleri, C Bengala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Tamoxifen rechallengeP Pronzato, A Ardizzoni, R Lionetto, et al.
Cancer Treatment Reviews|September 25, 2017
Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?F Miglietta, M V Dieci, G Griguolo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1985
Regional intra-arterial chemotherapy of metastatic liver cancerL Santi, D Civalleri, P F Conte, et al.
European Journal of Gynaecological Oncology|January 1, 1994
Therapeutic experience of the North-West Oncology Group (GONO) on ovarian carcinomaP F Conte, A Gadducci, P Fioretti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1987
4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot studyM Bruzzone, S Chiara, A Falcone, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancerP F Conte, A Alama, R Favoni, et al.
Pageof 20